Загрузка...
Pyrazolyl-pyrimidones inhibit the function of human solute carrier protein SLC11A2 (hDMT1) by metal chelation
Solute carrier proteins (SLCs) control fluxes of ions and molecules across biological membranes and represent an emerging class of drug targets. SLC11A2 (hDMT1) mediates intestinal iron uptake and its inhibition might be used to treat iron overload diseases such as hereditary hemochromatosis. Here w...
Сохранить в:
| Опубликовано в: : | RSC Med Chem |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal Society of Chemistry
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649969/ https://ncbi.nlm.nih.gov/pubmed/33479694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0md00085j |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|